|
WO03098046A1
|
|
Pump system for pumping liquefied gases
|
|
AU2003222127A1
|
|
Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
|
|
EP1281075A2
|
|
Apparatus and method for multiple channel high throughput purification
|
|
AU7866100A
|
|
Methods of enhancing chemotherapy
|
|
US6388076B1
|
|
Protein tyrosine phosphatase-inhibiting compounds
|
|
US6358414B1
|
|
Pressure regulation apparatus and method for multiple channel high throughput purification
|
|
US6458273B1
|
|
Sample separation apparatus and method for multiple channel high throughput purification
|
|
US6355164B1
|
|
Sample collection apparatus and method for multiple channel high throughput purification
|
|
US6528324B1
|
|
Apparatus for pre-determined mass sorting of positional-encoded solid phase synthesis supports
|
|
AU2039800A
|
|
5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
|
|
US6309541B1
|
|
Apparatus and method for multiple channel high throughput purification
|
|
WO0026662A1
|
|
Apparatus and method for multiple channel high throughput purification
|
|
CA2289621A1
|
|
Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase)
|
|
MXPA00008921A
|
|
Modulators of protein tyrosine phosphatases.
|
|
US5976470A
|
|
Sample wash station assembly
|
|
US6171555B1
|
|
Reaction block docking station
|
|
US5965558A
|
|
Modulators of proteins with phosphotyrosine recognition units
|
|
US5840721A
|
|
Imidazole derivatives as MDR modulators
|
|
EP0812830A1
|
|
Modulators of multi-drug resistances
|
|
CA2207753A1
|
|
Modulators of multi-drug resistances
|
